The JNF site contains the necessary updated documents and is now open to submission.

 

Please note: the implementation of approved proposals is subject to future agreements between the funding agency and BGU. 

 

KKL-JNF Online Submission Service 

 

RDA Deadline: March 11, 2019
RDA Contact: Tal Rafaely    Tel: 64 77709 

 

The NSF-BSF Materials, with the Division of Materials Research (DMR) , supports applications in two focus areas: 

• Ceramics  (CER)
  
• Condensed Matter and Materials Theory (CMMT)
  

Call Details

These programs have no deadlines and submission is welcome throughout the year. 
 

RDA Contact: Galia Chelets   Tel: 64 72436

 

Swiss Bridge is a private foundation associated with the Swiss Cancer League, the Swiss Cancer Research Foundation and the Union for International Cancer Control (UICC), and supports high-quality cancer research in Europe.

 

This year, young investigators with projects focusing on immune cell therapy are eligible for application.

 

Swiss Bridge Call Details
Swiss Bridge Previous Award Winners

 

RDA Deadline for LOI: April 17, 2019

Foundaiton Deadline: April 30, 2019 (after Passover break) 

 REMINDER- ERA NET Calls- Personalized  Medicine

 

The Israel Ministry of Health and EU Joint Programmes, ERA PerMed, and Neuro--degenerative Disease Research (JPND) have published two calls that focus on Personalized Medicine:

 

ERA PerMed Call on Personalised Medicine

 

The current call will comprise three Research Areas: 

 

Research area 1: "Translating Basic to Clinical Research and Beyond"

Research area 2: "Integrating Big Data and ICT Solutions"

Research area 3: "Research towards Responsible Implementation in Health Care"

 

ERA PerMed Call Text
ERA PerMed Programme Website

 

RDA Deadline: March 3, 2019

 

Personalized  Medicine for Neuro-degenerative Diseases 

 

The Call will focus on Precision Medicine in the following research areas: 

 

Diagnosis

Prevention

Care

 

This joint programme will fund research projects on Personalised Medicine, that may, in time, bring about the delivery of targeted and timely prevention and therapies for patients of the following neurodegenerative diseases:
- Alzheimer’s disease and other dementias
- Parkinson’s disease and PD‐related disorders
- Prion diseases
- Motor neuron diseases
- Huntington’s disease
- Spinocerebellar ataxia (SCA)
- Spinal muscular atrophy (SMA)

 

JPND Call Text
JPND Programme Website

 

RDA Deadline: March 6, 2019

 

Each consortium submitting a proposal must involve 3-6 partners from at least 3 different countries participating in the call.

 

RDA Contact: Lori Liss      Tel: 64 72435